DXJ vs. ARKG ETF Comparison
Comparison of WisdomTree Japan Hedged Equity Fund (DXJ) to ARK Genomic Revolution Multi-Sector ETF (ARKG)
DXJ
WisdomTree Japan Hedged Equity Fund
DXJ Description
The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree Japan Hedged Equity Index. Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in component securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such component securities. The index is designed to provide exposure to Japanese equity markets while at the same time neutralizing exposure to fluctuations of the Japanese yen relative to the U.S. dollar. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$105.28
Average Daily Volume
1,017,238
9
ARKG
ARK Genomic Revolution Multi-Sector ETF
ARKG Description
Companies within ARKG are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business. The companies held in ARKG may develop, produce or enable: CRISPR Targeted Therapeutics Bioinformatics Molecular Diagnostics Stem Cells Agricultural Biology ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry. ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund’s investment theme of the genomics revolution.Grade (RS Rating)
Last Trade
$22.78
Average Daily Volume
2,348,290
37
Performance
Period | DXJ | ARKG |
---|---|---|
30 Days | -0.54% | -16.00% |
60 Days | 4.08% | -21.47% |
90 Days | 12.82% | -19.65% |
12 Months | 55.14% | -20.86% |
0 Overlapping Holdings
Symbol | Grade | Weight in DXJ | Weight in ARKG | Overlap |
---|
DXJ Underweight 37 Positions Relative to ARKG
Symbol | Grade | Weight | |
---|---|---|---|
CRSP | F | -7.29% | |
TWST | C | -6.12% | |
EXAS | D | -5.57% | |
RXRX | F | -5.18% | |
SDGR | F | -4.75% | |
IONS | D | -4.31% | |
BEAM | F | -3.94% | |
NTLA | F | -3.9% | |
ACCD | D | -3.68% | |
ARCT | F | -3.67% | |
CDNA | F | -3.66% | |
TXG | F | -3.64% | |
DNA | F | -3.48% | |
TDOC | F | -3.36% | |
MRNA | A | -3.04% | |
VEEV | D | -2.81% | |
VCYT | D | -2.8% | |
NRIX | B | -2.79% | |
VRTX | C | -2.67% | |
ADPT | F | -1.94% | |
MASS | F | -1.7% | |
INCY | F | -1.63% | |
VERV | F | -1.53% | |
QSI | F | -1.47% | |
CMPS | F | -1.39% | |
ABSI | D | -1.31% | |
PACB | F | -1.27% | |
REGN | C | -1.24% | |
PRME | F | -1.13% | |
PATH | D | -1.11% | |
AMGN | C | -1.03% | |
CERS | F | -1.02% | |
BFLY | F | -0.7% | |
RPTX | F | -0.65% | |
PSNL | D | -0.59% | |
NTRA | A | -0.56% | |
GH | F | -0.45% |
DXJ: Top Represented Industries & Keywords
ARKG: Top Represented Industries & Keywords